> New SEMPORA Study on UK Pharmacy Market 2010/2011
SEMPORA Consulting has produced a new study on the UK pharmacy market based on new surveys of market participants. 1
We have revisited our 2008 study by seeking up to date opinions from manufacturers, pharmacists and consumers on various current issues and future challenges.
Key findings are:
- NHS reform is the single biggest concern for all participant groups.
- Internet pharmacy remains a small channel but there is increasing consumer interest.
- Consumers have become more price sensitive.
1 Surveys kindly supported by 'OTC Bulletin' and 'The Proprietary Association of Great Britain'.
Price: £ 300.00
For further information please contact Francis Prosser or Daniela Scholz.´
> SEMPORA Study: UK VAT increase January 2010 - Negative effects anticipated by retailers and consumers
Industry snapshot indicates how return to 17.5% standard rate VAT will affect retailers, producers and consumers.
UK consumers could face a double hit when VAT goes back up to 17.5% on 1st January 2010. According to a recent study by SEMPORA Consulting, London, around a third of retailers are looking at using the opportunity to make additional price increases on top of the VAT increase. There is some comfort for shoppers - while 50% of retailers intend to pass on at least the full amount of the VAT increase, 21% said they were planning to pass on only part of the additional cost and 29% indicated that they would hold prices at current levels. As a result, the VAT increase is also likely to put extra pressure on company profits and trading relationships between suppliers and retailers.
As part of this study, SEMPORA surveyed 129 consumers as well as 108 senior managers at leading companies in retailing and manufacturing.
Price: £ 250.00
> SEMPORA Market Survey: The UK pharmacy market 2008
"Tougher competition in the UK pharmacy market will lead to the loss of another 1,200 pharmacies in the next five years"
The strong growth of retail chain and supermarket pharmacies along with recent changes to the Pharmacy Contract, new POM-to-P switches, increasing numbers of generic and retail own label products and falling retail prices for OTC medicines, make the UK an increasingly tough market, according to a survey conducted by the management consultancy SEMPORA Consulting.
Current market conditions and future developments are increasing pressure on pharmaceutical companies and UK retail pharmacies to overhaul their strategies for marketing, sales, product portfolios and pricing.
Price: £ 350.00